Our vision is to make fastest quality diagnostics accessible to anyone, to allow for right treatment at the right time and to provide near patient diagnostics that can be used with as little laboratory equipment and training as possible. With CYCLE® Dx and Lab-direct we have developed two unique patented technology platforms, both enabling for SAFE-molecular diagnostics: Secure = receive reliable results from our certified systems Advanced = get multiple parameters for pathogen testing while using one-step protocols Fast = <30min from sample to result Easy = usable by everyone with no or only little laboratory equipment Thus, our COVID-19 direct RT-PCR kits from the Lab direct series are designed to detect SARS-CoV-2 RNA and COVID-19 mutation(s) in parallel directly from the unprocessed patient sample without any previous additional sample preparation steps, such as RNA extraction. In addition, all COVID-19 direct RT-PCR kits employ a user-friendly one-step protocol from sample to result, significantly reducing handling effort and time. Furthermore, our CYCLE® Dx platform technology provides for multi-parametric, rapid, sensitive and fully automated molecular testing truly at the Point-of-Care. CYCLE® Dx provides the complete diagnostic workflow in a miniaturised environment and transfers Point-of-Care testing to the next level: Gather all information needed in a miniaturised, lab-free environment at highly cost-effective set up. We are based in Neuried, with over 350 qm2 state-of-the-art R&D facilities as well as a sophisticated in-house pilot production-site. Here, our diverse team of highly skilled chemists, biologists and physicists with an extensive experience in molecular diagnostics development is dedicated to constantly provide and further develop our latest technologies.